Stem, Inc.STEMNYSE
Loading
R&D Expense Growth Recovery in ProgressRecovering
Percentile Rank48
5Y CAGR-50.0%
Studio
Year-over-Year Change

Year-over-year research & development expense growth

5Y CAGR
-50.0%/yr
Long-term compound
Percentile
P48
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 qtr
Consecutive growthRecovering
PeriodValue
Q4 20252.05%
Q3 2025-30.79%
Q2 2025-11.78%
Q1 20255.09%
Q4 2024-2.77%
Q3 2024-27.45%
Q2 20248.10%
Q1 2024-49.49%
Q4 202394.09%
Q3 20231.86%
Q2 20235.30%
Q1 202336.20%
Q4 2022-6.22%
Q3 202217.44%
Q2 20220.22%
Q1 202223.85%
Q4 202115.20%
Q3 202129.85%
Q2 20219.53%
Q1 2021-47.27%
Q4 202065.42%
Q3 202039.60%
Q2 20206.60%
Q1 2020-45.48%
Q4 20190.00%
Q3 20190.00%